Main Conference Day 2
Main Conference Day 2
7:45am - 8:10am25 mins
Main Conference
Registration and Coffee
8:10am - 8:15am5 mins
Main Conference
Chairperson’s Remarks
8:15am - 8:45am30 mins
Main Conference
Learn How Electrostatic Drying Technology Can Help
- Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
Plenary Session
8:45am - 9:15am30 mins
mRNA Advances Track
Chemical Synthesis of mRNAs Based on Efficient Capping Reaction
- Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
9:15am - 9:45am30 mins
mRNA Advances Track
Advancing Oligonucleotide and mRNA Therapeutics: TUG1 ASO for Recurrent Glioblastoma and Runx1 mRNA for Knee Osteoarthritis
- Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
9:45am - 10:15am30 mins
mRNA Advances Track
Advances in mRNA-based Therapeutics for Protein Replacement
- Pad Chivukula, PhD - Chief Scientific Officer and COO, Arcturus Therapeutics
10:15am - 10:55am40 mins
Networking Refreshment Break with Poster and Exhibit Viewing
Networking Refreshment Break with Poster and Exhibit Viewing
10:20am - 10:35am15 mins
TIDES Talks in the Exhibit Hall
TIDES Talk
Concurrent Conference Tracks
10:55am - 11:00am5 mins
Oligonucleotide Track
Chairperson’s Remarks: Track 1
- Yogesh Sanghvi, PhD - President, Rasayan Inc.
10:55am - 11:00am5 mins
Peptide Track
Chairperson’s Remarks: Track 2
11:00am - 11:30am30 mins
Oligonucleotide Track
Formulation Innovations for Future Oligonucleotide Therapies: Insights Inspired by Biologics
- Tomoya Takenaka, PhD - Principal Scientist, Drug Product and Device Development, Takeda Pharmaceutical Company
11:00am - 11:30am30 mins
Peptide Track
Late Breaking Presentation
11:30am - 12:00pm30 mins
Oligonucleotide Track
Insights into siRNA Duplex Stability and Formulation Screening by UV-Vis and Rapid-screening DSC Thermal Analyses
- Molly Blevins, PhD - Principal Scientist, Genentech
11:30am - 12:00pm30 mins
Peptide Track
Late Breaking Presentation
12:00pm - 12:30pm30 mins
Oligonucleotide Track
Achieving Quality and Regulatory Confidence in Oligo Therapeutics with Advanced Purification
- Alun Garner - Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies
12:00pm - 12:30pm30 mins
Peptide Track
Late Breaking Presentation
12:30pm - 1:40pm70 mins
Oligonucleotide Track
Networking Luncheon with Poster and Exhibit Viewing
12:30pm - 1:40pm70 mins
Peptide Track
Networking Luncheon with Poster and Exhibit Viewing
1:40pm - 1:45pm5 mins
Oligonucleotide Track
Chairperson’s Remarks: Track 1
- Yogesh Sanghvi, PhD - President, Rasayan Inc.
1:40pm - 1:45pm5 mins
Peptide Track
Chairperson’s Remarks: Track 2
- Ved Srivastava, PhD - CTO, Perpetual Medicines
1:45pm - 2:15pm30 mins
Oligonucleotide Track
Understanding UF/DF Capabilities for Enhancing ASO Processing to Make a Liquid or Lyo API
- Robert Gronke, PhD - Senior Principal Scientist, Biogen, Inc
1:45pm - 2:15pm30 mins
Peptide Track
Switching off Transcription Factors Using Intracellular Library-derived Peptides
- Jody Mason, PhD - Professor of Biochemistry, University of Bath
2:15pm - 2:45pm30 mins
Oligonucleotide Track
Oligo CMC Presentation
2:15pm - 2:45pm30 mins
Peptide Track
Mixed-Chirality Prohibitin Peptides Enhance Stability and In Vivo Effects on Obesity
- David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
2:45pm - 3:15pm30 mins
Oligonucleotide Track
Challenges of Raw Material Acquisition for Oligonucleotide Synthesis
- Long Ma, PhD - CEO and Chief Scientist, Orilife Biotech
2:45pm - 3:15pm30 mins
Peptide Track
Selection of Constrained Peptides as Functional Modulators of CB2R and Characterization of Functional Effects in IBD Models
- David O'Connell, PhD - Professor, School of Biomolecular & Biomedical Science, University College Dublin
3:15pm - 3:45pm30 mins
Oligonucleotide Track
Networking Refreshment Break with Poster and Exhibit Viewing
3:15pm - 3:45pm30 mins
Peptide Track
Networking Refreshment Break with Poster and Exhibit Viewing
3:45pm - 4:15pm30 mins
Oligonucleotide Track
Development and Manufacture of Oligonucleotides via Enzymatic Ligation
- Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
- Arne Berthelmann - Senior Director Oligonucleotide R&D, Bachem AG
3:45pm - 4:15pm30 mins
Peptide Track
Applying PeptiDream’s Peptide Discovery Platform System (PDPS) to Identify and Optimize Oral IL-17 Peptide Inhibitors for Psoriasis
- Haruaki Kurasaki, PhD - Director, Medicinal Chemistry, PeptiDream
4:15pm - 4:45pm30 mins
Oligonucleotide Track
Technology and Innovation in Oligonucleotide CMC
- Masafumi Iwamoto, PhD - Associate Director of Technology and Innovation, Nitto Denko Avecia
4:15pm - 4:45pm30 mins
Peptide Track
Harnessing Venom for Drug Discovery: Developing a High-Performance Venom Library Platform with a Machine Learning-Enabled Rapid Hit-to-Lead Workflow
- Yingnan Zhang, PhD - Senior Principal Scientific Manager, Genentech
4:45pm - 5:15pm30 mins
Oligonucleotide Track
Lessons Learned Building an Oligo CMC Program for a Small Company: Doing More with Less
- Pablo Lores Lareo, PhD - CMC Director, Sylentis
4:45pm - 5:15pm30 mins
Peptide Track
Antibody Peptide Conjugates: The Next Big Modality?
- Kerry Blanchard, MD, PhD - CEO, Chairman and Founder, Perpetual Medicines
5:15pm - 6:15pm60 mins
Oligonucleotide Track
Networking Cocktail Reception with Poster and Exhibit Viewing
5:15pm - 6:15pm60 mins
Peptide Track
Networking Cocktail Reception with Poster and Exhibit Viewing
6:15pm - 6:20pm5 mins
Oligonucleotide Track
Close of Day Two
6:15pm - 6:20pm5 mins
Peptide Track
Close of Day Two
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。